Development and in vitro characterization of floating sustained-release drug delivery systems of polyphenols. 2013

Ohad Rosenzweig, and Eran Lavy, and Irith Gati, and Ron Kohen, and Michael Friedman
Institute for Drug Research, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.

The aim of this study was to develop and characterize floating stomach-retentive matrix tablets that will deliver polyphenols in a controlled release manner. The tablets were prepared by direct compression. A number of polymers were examined and egg albumin was chosen in light of a better performance in terms of floating behavior and decomposition time. Dissolution studies for three representative polyphenols loaded into a number of formulations were performed using the "f₂" factor in order to compare release profiles of different polyphenols and formulations. The release data showed a good fit into the power law equation and zero-order kinetics has been determined for some of the systems. Erosion and textural analysis studies revealed that higher concentration of egg albumin results in a higher gel strength that is less susceptible to erosion, potentially leading to a prolonged delivery time of drug. The ability of egg albumin-based tablets to resist high mechanical forces was also determined, while comparison to cellulose-derived polymers revealed that the latter have a much lower ability to resist the same forces. The developed delivery system has the potential to increase the efficacy of the therapy for various pathological stomach conditions and to improve patient compliance.

UI MeSH Term Description Entries
D003692 Delayed-Action Preparations Dosage forms of a drug that act over a period of time by controlled-release processes or technology. Controlled Release Formulation,Controlled-Release Formulation,Controlled-Release Preparation,Delayed-Action Preparation,Depot Preparation,Depot Preparations,Extended Release Formulation,Extended Release Preparation,Prolonged-Action Preparation,Prolonged-Action Preparations,Sustained Release Formulation,Sustained-Release Preparation,Sustained-Release Preparations,Timed-Release Preparation,Timed-Release Preparations,Controlled-Release Formulations,Controlled-Release Preparations,Extended Release Formulations,Extended Release Preparations,Slow Release Formulation,Sustained Release Formulations,Controlled Release Formulations,Controlled Release Preparation,Controlled Release Preparations,Delayed Action Preparation,Delayed Action Preparations,Formulation, Controlled Release,Formulations, Controlled Release,Prolonged Action Preparation,Release Formulation, Controlled,Release Formulations, Controlled,Sustained Release Preparation,Timed Release Preparation,Timed Release Preparations
D012995 Solubility The ability of a substance to be dissolved, i.e. to form a solution with another substance. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Solubilities
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug
D055808 Drug Discovery The process of finding chemicals for potential therapeutic use. Drug Prospecting,Discovery, Drug,Prospecting, Drug
D059808 Polyphenols A large class of organic compounds having more than one PHENOL group. Polyphenol,Provinols

Related Publications

Ohad Rosenzweig, and Eran Lavy, and Irith Gati, and Ron Kohen, and Michael Friedman
January 2011, PDA journal of pharmaceutical science and technology,
Ohad Rosenzweig, and Eran Lavy, and Irith Gati, and Ron Kohen, and Michael Friedman
May 2024, Eye (London, England),
Ohad Rosenzweig, and Eran Lavy, and Irith Gati, and Ron Kohen, and Michael Friedman
July 2011, Expert opinion on drug delivery,
Ohad Rosenzweig, and Eran Lavy, and Irith Gati, and Ron Kohen, and Michael Friedman
September 1984, Yao xue xue bao = Acta pharmaceutica Sinica,
Ohad Rosenzweig, and Eran Lavy, and Irith Gati, and Ron Kohen, and Michael Friedman
January 2013, International journal of pharmaceutics,
Ohad Rosenzweig, and Eran Lavy, and Irith Gati, and Ron Kohen, and Michael Friedman
January 1993, The Journal of pharmacy and pharmacology,
Ohad Rosenzweig, and Eran Lavy, and Irith Gati, and Ron Kohen, and Michael Friedman
January 2003, The Indian journal of chest diseases & allied sciences,
Ohad Rosenzweig, and Eran Lavy, and Irith Gati, and Ron Kohen, and Michael Friedman
October 2020, Molecular pharmaceutics,
Ohad Rosenzweig, and Eran Lavy, and Irith Gati, and Ron Kohen, and Michael Friedman
March 2017, Journal of pharmaceutical sciences,
Ohad Rosenzweig, and Eran Lavy, and Irith Gati, and Ron Kohen, and Michael Friedman
January 1989, Medical progress through technology,
Copied contents to your clipboard!